Treatment related changes in antifibrinolytic activity in patients with polycythemia vera

Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms

(2009) Domenica Caramazza et al.   ANNALS OF HEMATOLOGY

Blood cell activation in myeloproliferative neoplasms

(2009) F. Cervantes et al.   HAEMATOLOGICA

Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients

(2008) Emmanouil Spanoudakis et al.   ANNALS OF HEMATOLOGY

Myeloproliferative disorders

(2008) R. L. Levine et al.   BLOOD

Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy

(2008) F. Girodon et al.   HAEMATOLOGICA

Prevention of thrombosis in polycythemia vera and essential thrombocythemia

(2008) R. Landolfi et al.   HAEMATOLOGICA

Evidence and expertise in the management of polycythemia vera and essential thrombocythemia

(2008) G Finazzi et al.   LEUKEMIA

Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation

(2008) R Landolfi et al.   LEUKEMIA